Alhussein A. Ibrahim

Dr. Alhussein A. Ibrahim

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2003 in Zeitschrift für Naturforschung B
Verified
Journal Article
Closed access
PDF file
Abd El-Galil Elsayed AmrAbd El-Galil Elsayed Amr
Abd El-Galil Elsayed Amr
AMAshraf Mohamed
Ashraf Mohamed
AIAlhussein A. Ibrahim
Alhussein A. Ibrahim
A series of chiral macrocyclic pyridines has been prepared starting from N2,N2-(pyridine- 2,6-dicarbonyl)diamino acid hydrazides (2a-c) and N,N-bis-(1-carboxy-2-substituted)-2,6- diaminocarbonyl)pyridines (3a,b). The coupling of (2a-c) with 2,6-pyridine dicarbonyldichloride (4) gave the compounds (5a-c). Compounds 2a-c were coupled with 2,6-diacetylpyridine (6) to yield compounds (7a-c) and with heterocyclic aldehydes (8) or (10) to give the compounds (9a-c) or (11a-c). In addition, the hydrazides (2a-c) were reacted with diformylcalix[4]arene 12 to afford the macrocyclic calix[4]arene hydrazone derivatives (13a-c) in reasonable yields. Finally, reaction of diaminocalix-[4]arene derivatives (14a,b) with hydrazides 2a,b or acids (3a,b), using azide or mixed anhydride methods afforded macrocyclic calix[4]arene derivatives 15a,b and 16a,b, respectively. The structure assignments of the new compounds are based on chemical and spectroscopic evidence. The biological activity screening tests showed that many of the obtained compounds exhibit high antimicrobial activity comparable to ampicillin and chloramphenicol which are used as reference compounds.

23 July 2016 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Closed access
PDF file
MSM. H. Sanad
M. H. Sanad
AEA. S. A. El-Bayoumy
A. S. A. El-Bayoumy
AIAlhussein A. Ibrahim
Alhussein A. Ibrahim

2 November 2017 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Closed access
PDF file
MSM. H. Sanad
M. H. Sanad
AIAlhussein A. Ibrahim
Alhussein A. Ibrahim
HTH. M. Talaat
H. M. Talaat

13 June 2018 in Radiochimica Acta
Verified
Journal Article
Closed access
PDF file
HSH. M. Sanad
H. M. Sanad
AIAlhussein A. Ibrahim
Alhussein A. Ibrahim
The present work has been oriented to prepare radioiodinated olmesartan for a potential cardiac imaging. Olmesartan has been labeled using125I or131I with N-bromosuccinimide (NBS) as an oxidizing agent. Many factors like amount of N-bromosuccinimide, amount of substrate, pH, reaction temperature and reaction time, have been systematically studied to optimize high yield of [125I]iodoolmesartan. The biological distribution indicates the suitability of [125I]iodoolmesartan as a novel tracer to image heart.

21 October 2017 in Radiochimica Acta
Verified
Journal Article
Closed access
PDF file
MSM. H. Sanad
M. H. Sanad
AIAlhussein A. Ibrahim
Alhussein A. Ibrahim
In the present work, [99mTc]N-histamine has been labeled using [99mTc≡N]2+ core. Factors such as, amount of substrate, pH, reaction temperature, in vitro stability and reaction time, have been systematically studied to optimize high radiochemical purity (>99±0.3). Biodistribution studies indicate the suitability of [99mTc]N-histamine as a novel tracer to image brain. The complex of [99mTc]N-histamine may be considered a highly selective radiotracer for brain imaging.

1 February 1999 in Tetrahedron Letters
Verified
Journal Article
Closed access
YMYuji Miyahara
Yuji Miyahara
KIKenji Izumi
Kenji Izumi
AIAlhussein A. Ibrahim
Alhussein A. Ibrahim
TITakahiko Inazu
Takahiko Inazu